BioNSW Committees
Industry leaders volunteer their expertise across six sector-specific committees.
Biopharma
The Biopharma Committee guides biotech companies through their development journey by sharing practical, real-world insights. It tackles emerging and under-represented topics, fosters networking across the biotech community and raises BioNSW's profile in support of our three pillars: Connect, Promote and Represent. The Committee also sponsors the BioNSW Life Sciences Awards.
Digital Health
The Digital Health and Technology Committee (DHTC) represents BioNSW members and connects sector experts committed to advancing digital health capability across New South Wales. It builds collaborations with key stakeholders to share insights, identify opportunities and support the development, regulation and responsible adoption of digital technologies that champion patient-centred healthcare delivery.
Medtech
The Medtech Committee is the voice of the medical technology sector within BioNSW, connecting, promoting and representing medtech businesses to grow the sector's economic contribution to NSW. It does this through advocacy on sector issues, member events and networking, and initiatives that address gaps in skills, manufacturing capability, funding and procurement.
Investment
The Investment Committee aims to strengthen life sciences investment by educating investors and investees on capital sources, returns and fundraising, and by building networks that connect companies with domestic and international equity and debt providers. It also assesses the sector's economic benefits and considers advocacy to improve investment practices across the industry.
Manufacturing
The Manufacturing Committee promotes and strengthens manufacturing capability across the pharmaceutical, biopharmaceutical and medical device sectors in NSW. Through strategic planning, collaboration and policy engagement, it aims to drive innovation, improve production efficiency, uphold high-quality standards and foster growth in these industries, which are critical to the state's economy.
Chair
Members
Innovation & Commercialisation
The Innovation & Commercialisation Committee supports the translation of life sciences innovation into commercial and real-world impact across biotech, medtech, healthtech, agtech and synthetic biology. It gives founders, researchers and technology transfer offices practical expertise across the journey from discovery through licensing, venture creation, market entry and growth, helping more promising ideas reach market.